chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Droopy side of left side of mouth and face.  Went to hospital that evening and was admitted.  Diagnosis was Bells Palsy. 2 Days in hospital and put on Prednisone for 10 Days.
Knee caps out of place to strengthen; Slipped on ice and made knee swell and ankles and elbow swelling; Slipped on ice and made knee swell and ankles and elbow swelling; Patient received covid-19 vaccine booster dose; Patient received covid-19 vaccine booster dose; This is a solicited report based on the information received by Pfizer from AbbVie Inc. (MFR Control No. # 21K-163-4074903-00). A contactable 31-year-old female consumer (patient) received third of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot Number: was not reported), via intramuscular route of administration on an unspecified date (age at the time of vaccination 31-years-old), as a single dose for COVID-19 immunization; and Humira (solution for injection in pre-filled pen) (adalimumab), via Subcutaneous, on an unspecified date for Moderate to severe Rheumatoid Arthritis, and Psoriatic Arthritis. The patient's medical history and concomitant medications were not reported. Patient previously received first dose of BNT162B2 vaccine on an unspecified date, as a single dose for COVID-19 immunization, and second dose of BNT162B2 vaccine on an unspecified date, as a single dose for COVID-19 immunization. On an unspecified date, the patient experienced Knee caps out of place to strengthen, Slipped on ice and made knee swell and ankles and elbow swelling, and Patient received covid-19 vaccine booster dose. It was unknown if patient was enrolled in a covid-19 vaccine trial. The reporter's assessment of the causal relationship of the event with the suspect product was not provided at the time of this report. Since no determination has been received, the case is managed based on the company causality assessment. The outcome of the events Knee caps out of place to strengthen was not recovered; and Slipped on ice and made knee swell and ankles and elbow swelling was recovered on an unspecified date; and Patient received covid-19 vaccine booster dose was unknown.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on the available information in the narrative the causality between the suspect vaccine BNT162B2 and the events Fall, Joint dislocation and Joint swelling were considered Unrelated since these happened due to Accidental Injury. Events Off label use and Immunization were assessed as Related.
Chronic spontaneous urticaria with no obvious cause started on Dec 26, 2021. Increased in severity, before being treated with prednisone and then a combination of cetirizine and famatodine
2 mo check up and vaccines given - 5/20/14. Fever next day to 102 and seen in ED. Cultures drawn and sent home. Better 5/22 and 5/23. 5/24 -> Fever returned with significantly increased abd pain. 5/25 -> Sent to ED and admitted. Abd ultrasound showed small bowel intussusception that resolved during US. Sent home next day and has improved.
This case was reported by a physician via sales rep and described the occurrence of myalgia in a 15-year-old female patient who received BEXSERO for prophylaxis. Co-suspect products included GARDASIL for prophylaxis. On 13th August 2018, the patient received BEXSERO .5 ml and GARDASIL. On an unknown date, less than a month after receiving BEXSERO, the patient experienced myalgia, arthralgia, malaise and influenza-like symptoms. The patient was treated with MOTRIN. On an unknown date, the outcome of the myalgia, arthralgia, malaise and influenza-like symptoms were recovered/resolved. It was unknown if the reporter considered the myalgia, arthralgia, malaise and influenza-like symptoms to be related to BEXSERO. Follow up information received from nurse via licensee on 11th September 2018: The patient's mother was the reporting physician. The patient received BEXSERO in the left arm. The patient also received GARDASIL (HPV) at the same time. The symptoms lasted for 24 hours. The patient did take Motrin. This case was linked to the case US2018GSK164081, reported by the same reporter.
seizures starting @ 3AM ; t100.1 R; hx of sz; given Phenobarb in Er & adm for observation;
Patient work up in the middle of the night feeling nausea and had arm pain  in joint . Patient noticed light bruising on inside of arm up to shoulder and over to breast area.
My Sister, Brother, and I got moderna booster shots in left arm. Since shots have been having right shoulder pain in all of us
Rapid onset of extreme fatigue, became very cold, fever of 101.6, headache, and very sore at injection site. Lasted about 12 hours.
One of the two finger flanges broke off; The vaccine was still administered to the patient as the finger flnage breaking off was the only defect.; This spontaneous report was received from a Licensed Practical Nurse, referring to a 76 year old male patient. Information regarding the patient's pertinent medical history, concurrent conditions and concomitant therapies was not provided. The patient had no known allergies.      On 28-SEP-2021, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), with lot # U003306 has been verified to be a valid lot number and expiration date, on a dose of 0.5 milliliter, by intramuscular route in the right arm, as it was age appropriate.   It was reported that, on the same date, while the physician was administering pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23), one of the two finger flakes broke off (syringe issue and poor quality product administered). It was reported that the physician, cut his finger and it required a band aid (captured in MARRS # 2110USA004833). It was also reported that, the vaccine was still administered and that the patient did not even know what happened.  The vaccine was not able to be retrieved as the physician disposed the pieces into sharp container.  This is one of two cases received by the same reporter. ; Sender's Comments:  US-009507513-2110USA004833:
Client received the 1st COVID vaccine (Pfizer, Lot # EW0187, EXP: 07/10/2021) at 14:38. EMT reported to PHN of patient reporting of dizziness and nausea. Client is alert and oriented to person, place, time and date. Guardian of patient was present and reported patient hasn?t eaten since breakfast and reports a history of dizziness and anxiety and no known allergies to medications or food. At 14:43 patients? vitals were taken; blood pressure 110/70, heart rate 75, oxygen saturation 99, patient was given a granola bar. At 14:47 patient stated, ?nausea is subsiding?, at 14:50; blood pressure 112/82, heart rate 84, oxygen saturation 99. Patient and guardian was encouraged to stay 30 minutes for observation. PHN advised client and guardian to follow up with primary care provider and gave ER precautions. Patient denies any further nausea or dizziness. At 15:01 client left facility with a steady gait, accompanied by guardian.
Hematoma about 7" long and 3" wide after slightly bumping with piece of lumber. Never had anything like this before.
Patient presented with acute hypoxic respiratory failure, acute CHF exacerbation and NSTEMI. Cardiology was consulted and he was started on aggressive IV diuretic regimen for diuresis and had a net -26.9 L of fluid removed.  He was switched to torsemide at time of discharge.  He is enrolled in the CHF program and will follow up there after discharge. Patient passed away in hospice on 9/2021. Hospital visit was within 6 weeks of receiving the COVID vaccine.
Initial report was received 12 September 2008 from another manufacturer who received the report from a health care professional. An unidentified patient had received an injection of Tetanus Toxoid (lot number, date, route/site of administration not reported) and an unspecified amount of time later, experienced an anaphylactic reaction. The manufacturer of the Tetanus Toxoid vaccine was unknown. No additional information was provided.
hives devel all over body approx 8PM 15JUN93 taken to hosp ER; Adrenaline & DPH given; hives resolved; No fever; hives again 16JUN93; oral DPH given & hives resolved;
Numbness noted to left arm, radiating from injection site to hand. Ice pack applied to injection site. Symptoms resolved within 15 minutes.
Reported decreased range of motion to left arm/shoulder, aching pain, swelling, inability to lift arm for few days. Took ibuprofen for pain and swelling with minimal relief.
Fever (101F) from midnight 6/4 to midnight 6/5 Insomnia (first night) Weakness (unable to sit or stand for more than a minute) all of 6/4 - better today, but still experiencing fatigue Severe joint pain ( 6/3 and 6/4) Nausea (early morning and afternoon of 6/4) swollen lymph nodes (collarbone, and left armpit) from about 1100h 6/3 and continuing today (6/5)
No additional AE/PQC; HCP called to report patient was given a dose of PROQUAD that was stored outside of prescribing information temperatures. Product TE outcome was supported( case 02370482); This spontaneous report has been received from a health care professional, regarding a 1-year-old female patient. The patient's pertinent medical history, previous drug reactions or allergies and concomitant medications were not reported.  On 11-APR-2023, the patien was vaccinated with an improperly storage dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) injection, at a dose of 0.5 milliliters (ml) subcutaneously in the left arm on a private doctor's office/hospital with public funds as prophylaxis (lot number: W036931, which was determined to be valid, with an expiration date on 19-MAY-2024).  The administered dose underwent a temperature excursion of 9.8 degrees Fahrenheit (F) for 1 hour and 42 minutes as a result of a reading from a digital data logger, because the power blipped, and the temperature went up to 9.8 degrees Fahrenheit (F) for 1 hour and 43 minutes. There was not any previous temperature excursion reported. (Product storage error)  No additional adverse event was reported, and no further information provided.   This case is one of two reports from the same reporter.
After receiving the vaccine, the patient-reported "not feeling well" and then turned pale/ felt like she was going to pass out. The patient was placed in a reclining chair and given juice/crackers for 20-30 minutes and reported a vast improvement. Patient-reported no other signs of allergic reaction and stated that this has happened to her in the past with vaccinations.
Rash on (R) upper arm c/w shingles - early- feverish, chills, fatigue - 2 wks after Varicella vaccine.
symptomatic COVID after 2 doses of Moderna COVID-19 Vaccine 11/28/21: pt starts having cough followed by runny nose, nasal congestion and fever (no chills, SOB, CP, vomiting or diarrhea) 12/6/21: pt presents to Hospital ED with cough, fever and positive COVID-19 test 12/11/21: pt transferred to Hospital for management of COVID-19 Pneumonia and hyponatremia (too late for monoclonal antibody referral so patient was treated with O2, zn, remdesivir and dexamethasone) 12/17/21: pt discharged
Info has been received from a licensed practical nurse concerning her 14-year-old son who is a student with allergies to "sulfa", bee stings, grass, molds and trees who on 12/02/2002 at 7:00 PM was vaccinated IM in the deltoid with a 1st dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M). There was no illness at the time of vaccination. Concomitant therapy that day at 7:00 PM included a 1x every 5 year dose of influenza virus vaccine (FLUZONE) (Batch #U0925AA) given IM in the opposite deltoid. Additional concomitant medications included cetirizine hydrochloride (ZYRTEC) and an allergy injection for bees, grass, trees and mold. Subsequently, the pt developed redness and induration from his elbow to his shoulder. It was reported that symptoms resolved without treatment in a couple of days. Follow up info received from a licensed practical nurse indicated that on 12/03/2002 at 8:00 AM the pt developed pain, redness and swelling, and the area from the shoulder to the elbow was hot to the touch. No medical care was required as a result of the reaction. It was noted that on 12/09/2002 the pt recovered. There were no adverse events following prior vaccinations. The reporter indicated that 9 other pts received a dose of pneumococcal vaccine 23 polyvalent (Lot #643251/0445M) and developed induration at the injection site (WAES #0212USA00729, 0212USA00825, 0212USA01192, 0304USA02075, 0304USA02076, 0304USA02077, 0304USA02078, 0304USA02079 and 0304USA02081). No further info is expected.
Beginning two days after the vaccination, patient developed sharp/burning pain radiating through the left arm and shoulder.  The vaccine was administered in the left deltoid.
Patient received AFLUIRA at her workplace (administered by worker from Pharmacy) on October 6, 2017. Patient developed significant left arm pain immediately following the injection. On October 7, 2017, she developed significant aches/myalgia's (neck/upper back), headache and low grade fever (99.4 degrees) that persisted for more than a month (last contact with patient). Patient had never received this particular type of Flu shot before and attributed her symptoms to the AFLURIA.
Red inflammation area approx 4"x4" around injection site, fever of area, itchy, achy, soreness.
Vaccine stored in refrigerator on 29-Oct-2021, product expired on 13-Oct-2021, administered date on 09-Nov-2021; dose was given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 29-Oct-2021, product expired on 13-Oct-2021, administered date on 09-Nov-2021) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Nov-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 29-Oct-2021, product expired on 13-Oct-2021, administered date on 09-Nov-2021). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose was given after expiration date) and PRODUCT STORAGE ERROR (Vaccine stored in refrigerator on 29-Oct-2021, product expired on 13-Oct-2021, administered date on 09-Nov-2021) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.   On 29-Oct-2021, the vial was initially stored in the refrigerator. The Vial did not go undergo any temperature excursion. The patient had no any adverse event post administration of expired vaccine.  Treatment information was not provided.
p/vax pt BP 158/80, 150/80, 150/70-pulse 100/min x 3;later 140/72, P98, resp 20;seen 2PM @ clinic;BP 118/84, P96;3:45 BP 126/80, P88, T98.2;
High blood pressure; high pulse; Stomach pain on one side of body; Pain; Vaccination adverse reaction; Fever >100 F; Pain Injection Site Left Arm; Body Aches; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of HYPERTENSION (High blood pressure), HEART RATE INCREASED (high pulse), ABDOMINAL PAIN UPPER (Stomach pain on one side of body), PAIN (Pain) and VACCINATION COMPLICATION (Vaccination adverse reaction) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included AMLODIPINE for an unknown indication.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, the patient experienced HYPERTENSION (High blood pressure), HEART RATE INCREASED (high pulse), ABDOMINAL PAIN UPPER (Stomach pain on one side of body), PAIN (Pain), VACCINATION COMPLICATION (Vaccination adverse reaction), PYREXIA (Fever >100 F), VACCINATION SITE PAIN (Pain Injection Site Left Arm) and MYALGIA (Body Aches). At the time of the report, HYPERTENSION (High blood pressure), HEART RATE INCREASED (high pulse), ABDOMINAL PAIN UPPER (Stomach pain on one side of body), PAIN (Pain), VACCINATION COMPLICATION (Vaccination adverse reaction), PYREXIA (Fever >100 F), VACCINATION SITE PAIN (Pain Injection Site Left Arm) and MYALGIA (Body Aches) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-Feb-2021, Blood pressure measurement: high (High) High. On 05-Feb-2021, Heart rate: high (High) High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Advil and applied heat on stomach.
SORENESS; FATIGUE; This spontaneous report received from a patient concerned a 22 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. Non-company suspect drugs included: adalimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose, frequency, and therapy dates were not reported for Crohn's disease. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced soreness, and fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with adalimumab was not reported. The patient was recovering from fatigue, and soreness. This report was non-serious.
via Spanish translator-child restarted immunizations d/+, no records available. Mother states child previous immunized. innuizations given. Child increased anxiety, listlessness, no  LOC, pupil dilated, BP 134/88 standing  skin cold, clammy. Pt responded post 15 mins. of Trendelenburg. School notify 2/21/2002.   No symptoms or treatment
Patient received her second pfizer vaccine today, 21 days after her first dose. Shortly after the vaccine, she felt lightheaded and fainted in the store, regaining consciousness shortly after.
Same day very tired, arm sore, and all over body aches. 24 hrs later had very painful, swollen lymph nodes under arm of injection site
Experienced an unusual headache on about April 8th.  It felt like it was behind my left eye, and in front of my left ear. Pain subsided in about an hour after resting. On April 28th, I experienced vaginal bleeding.  I awoke to a dry cough and felt the leakage.  The blood was bright red and I'd estimate 4-6 Tablespoons.  I feel light-headed, concerned, but otherwise fine.
inappropriate schedule of vaccine administered; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     No medical history was provided by the reporter. .     On 31-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (inappropriate schedule of vaccine administered) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details was reported. No treatment medication details was reported.; Reporter's Comments: This report refers to a case of inappropriate schedule of vaccine administered for mRNA-1273 (lot #unknown) with no associated AEs reported.
Information has been received from a medical assistant concerning a 17 month old female patient who on 17-DEC-2010 was vaccinated with a first 0.5 ml dose of PROQUAD (Merck) (Lot# 664340/0196Z Exp date 15-JUL-2011), SQ, and a first 0.5 ml dose of VARIVAX (Lot# 668409/0997Z Exp date 28-JUL-2012), SQ. Medical assistant mentioned that on 17-DEC-2010 the physician had ordered for a patient to received her first dose of VARIVAX (Merck) and MMR II, but the patient received PROQUAD (Merck) and VARIVAX (Merck). No adverse effects reported. Additional information has been requested.
why does a magnet stick to my arm where the shot was administered?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (why does a magnet stick to my arm where the shot was administered?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE REACTION (why does a magnet stick to my arm where the shot was administered?). At the time of the report, VACCINATION SITE REACTION (why does a magnet stick to my arm where the shot was administered?) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact
Pt. presented to clinic 3 days after (9/20/19) with (R) arm swelling & fever. Tx'ed with cool packs, ibuprofen
Out of nowhere got a headache felt extremely hot and dizzy. Then lost consciousness and fell to the ground. Was white as a ghost.  Once I came to my hand and arms were numb and tingling. I was sweating but cold. Ambulance was called and they took my vitals and blood sugar. Everything was normal. After about 10 mins I was able to stand and felt better after getting all of my color back. I have felt fine the rest of the day besides some fatigue and body aches.
eye irritation, itchy-sudden tickle cough-severe enough to make swallowing uncomfortable;(but no noticable throat swelling)-chills for 2hr then profuse sweating-shakes-heart palpatations-rapid pulse-feels faint-nausea;
Patient with history of COVID vaccines who admitted to the hospital with COVID detected PCR. Provider d/c note: "90 YO-year-old male with h/o MDS on Dacogen, AAA, chronic obstructive pulmonary disease, dm 2, hypertension, and dementia presented to the ED for a Hgb 5.2.  Patients clinical course complicated with recurrent blood transfusions (6 units PRBC), AKI, generalized weakness, asymptomatic COVID 19, BPH requiring straight caths, complicated UTI, stage 3 gluteal fold ulcer, and soft blood pressures.  Patient has progressive dementia with family concerns for returning home independently was accepted at SNF for further rehabilitation."
Started as numbness in my left hand, pinky and ring finger, when I slept at night. Moved to my right hand, pinky and ring finger as well. Started getting same feeling in my left leg, outside shin during the day. I have tingling in my head as well.
On 11/12/00, pt developed paresthesia of the right arm and leg. Pt was evaluated at college facility. MD felt symptoms were self-eliminating. Addtl info recvd 2/23/01 reported that the pt recovered from this experience. No further info is anticipated. This case is closed.
Headache Neck pain Fever/Chills Nausea/Vomiting Diarrhae